ViiV HEALTHCARE RANKS #1 IN PATIENTVIEW CORPORATE REPUTATION SURVEY
ViiV Healthcare is extremely proud to be the highest-ranked company in the PatientView ‘Corporate Reputation of Pharma – from the Perspective of Patient Groups’ report for the fourth year running, having this year achieved top scores across all seven of the evaluation indicators.
This recognition is testament to ViiV Healthcare’s strong focus and commitment to people living with HIV and the way we work in partnership with patient groups to play our part in responding to the HIV epidemic.
| Company |
Final Rank |
Average score across 7 indicators |
| ViiV Healthcare |
1 |
47.5% |
| AbbVie |
2 | 35.3% |
| Novartis |
3 | 26.0% |
| Novo Nordisk |
4 | 25.4% |
| Gilead Sciences |
5 | 26.1% |
| Grifols |
6 | 24.1% |
| Janssen |
7 | 23.4% |
| Roche |
8 | 22.0% |
| Lundbeck |
9 | 21.7% |
| Shire |
10 | 22.2% |
| UCB |
11 | 20.7% |
Click here to read the full PatientView press release
Media contacts
For our corporate press office, email: Rachel Jaikaran
OR call +44 7823 523 755
For US-specific media enquiries,email:audrey.x.abernathy@viivhealthcare.com
OR call +1 919 605 4521
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellowcard in the Google Play or Apple App store. By reporting side effects, you can help provide more information on the safety of this medicine.
If you are from outside the UK, you can report adverse events to GSK/ViiV by selecting your region and market, here.
